Filing metadata

Accession number
0001209191-23-019564
Form type
Form 3
Filer
Stoke Therapeutics, Inc.
CIK
CIK 1623526
Filed
Mar 17, 2023
Reporting period
Mar 15, 2023
Description
Initial ownership

Explore SEC Filings Hub